Overview
Robin Joyce is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Joyce is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Joyce is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 3 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
Locations
330 Brookline Avenue, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Robin M. Joyce
How do I make an appointment with Dr. Robin M. Joyce?
You can book an appointment with Dr. Robin M. Joyce by calling their office at 617-667-9920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robin M. Joyce a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robin M. Joyce is classified as an Distinguished expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robin M. Joyce specialize in?
While Dr. Robin M. Joyce is a Internal Medicine, they have specific expertise in Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Robin M. Joyce participate in research or clinical trials?
Yes. Dr. Robin M. Joyce has published 52 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Robin M. Joyce's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Robin M. Joyce accept my insurance?
Dr. Robin M. Joyce accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-667-9920 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Joyce isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Joyce isDistinguished. Learn about B-Cell Lymphoma.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Joyce isDistinguished. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Classical Hodgkin LymphomaDr. Joyce isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Joyce isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Gastric LymphomaDr. Joyce isDistinguished. Learn about Gastric Lymphoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow TransplantDr. Joyce isAdvanced. Learn about Bone Marrow Transplant.
- Chronic B-Cell Leukemia (CBCL)Dr. Joyce isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Follicular LymphomaDr. Joyce isAdvanced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Joyce isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myelomonocytic LeukemiaDr. Joyce isExperienced. Learn about Acute Myelomonocytic Leukemia.
- AgranulocytosisDr. Joyce isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Joyce isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Joyce isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.